Skip to main content

Table 2 Differential diagnosis of patients

From: Novel microRNA-based assay demonstrates 92% agreement with diagnosis based on clinicopathologic and management data in a cohort of patients with carcinoma of unknown primary

Patient group #

Group description

n (%)

High confidence of presentation clinical Dx

Presentation clinical Dx & microRNA test agreement

Final clinical Dx & microRNA test 1st result agreement

Final clinical Dx & microRNA test 2nd result agreement

1

microRNA-based results agree with Final Clinical Dx but not with Presentation Clinical Dx

18 (21.5)

3/18

0/18

16/18

2/18

2

microRNA-based test reported a single result which agreed with Final Clinical Dx and with Presentation Clinical Dx

33 (39.5)

22/33

33/33

33/33

0/33

3

microRNA-based test reported two results which agreed with Final Clinical Dx and with Presentation Clinical Dx

26 (31)

13/26

26/26

25/26

1/26

4

microRNA-based results are not consistent with Clinical Dx

7 (8)

0/7

0/7

0/7

0/7